Global Encephalopathy Treatment Market 2019-2023

Global Encephalopathy Treatment Market 2019-2023

About Encephalopathy

Encephalopathy is a disease that affects the functioning and structure of the brain. It can be temporary, permanent, or neonatal.

Technavio’s analysts forecast the Global Encephalopathy Treatment Market to grow at a CAGR of 4.75% during the period 2019-2023.

Covered in this report

The report covers the present scenario and the growth prospects of the encephalopathy treatment market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of encephalopathy across the globe.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

Technavio's report, encephalopathy treatment market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendor

• Bausch Health

Market driver

• Rise in initiatives to increase the awareness about encephalopathy disease management
• For a full, detailed list, view our report

Market challenge

• Adverse effects associated with available drugs
• For a full, detailed list, view our report

Market trend

• Emergence of novel treatment targets for encephalopathy
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2023 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

PRESS RELEASE

Technavio Announces the Publication of its Research Report - Global Encephalopathy Treatment Market 2019-2023

Technavio recognizes the following company as the key player in the global encephalopathy treatment market: Bausch Health.

Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the emergence of novel treatment targets for encephalopathy. Certain candidates are under investigation for the treatment of liver cirrhosis which is one of the leading causes of hepatic encephalopathy.”

According to the report, one driver influencing this market is the driven by the rise in initiatives to increase the awareness about encephalopathy disease management and effective treatment of encephalopathy. Most of the programs aim at providing co-pay assistance, educational material for hepatic encephalopathy, and treatment adherence support. The growing availability of such patient awareness programs for assistance in the management and treatment of encephalopathy is expected to boost the growth of the global encephalopathy market.

Further, the report states that one challenge affecting this market is the adverse side effects associated with available drugs. The growth of the market is impeded by the adverse side effects such as severe stomach pain, diarrhea, and flatulence due to the available drugs for the treatment of encephalopathy.

Companies Mentioned

Bausch Health